speaker-icon

Latest Posts

anavex_partex_partnership_Innoplexus

27

Jun 23

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to...
Read More
Kittu-Press-Release

9

Feb 23

AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros

The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Author name: Gunjan Bhardwaj

Gunjan Bhardwaj is the founder and CEO of Innoplexus, a leader in AI and analytics as a service for life science industries. With a background at Boston Consulting Group and Ernst & Young, he bridges the worlds of AI, consulting, and life science to drive innovation.

ontosight-discover

An AI-based solution to extract real-time insights from the ever-growing scientific data

The pharmaceutical industry saves millions of lives every year, and in doing so, it needs to constantly improve existing therapies, find new ones, and take advantage of the large volume of growing scientific and medical data. It is often a herculean task to access all relevant data in real time, let alone make connections in …

An AI-based solution to extract real-time insights from the ever-growing scientific data Read More »

Inside-the-cockpit-by_gunjan-bhardwaj

You Can’t Find the Needle If You Don’t Know It Exists

This blog is adapted from my book titled “Inside the Cockpit: Navigating the Complexity of Drug Development with AI and Blockchain”. Full copies are available here.  In December 2014, a twenty-nine-year-old investor named Vivek Ramaswamy bought a patent from GlaxoSmithKline (GSK) for $5 million. The patent covered an Alzheimer’s drug candidate that had failed GSK’s …

You Can’t Find the Needle If You Don’t Know It Exists Read More »

artificial-intelligence

How AI and Big Data is transforming the future of healthcare

Dr. Gunjan Bhardwaj with Shanna Landolt for an exclusive podcast on how AI and Big Data is transforming the future of healthcare. http://traffic.libsyn.com/force-cdn/highwinds/shannalandolt/Dr._Gunjan_Bhardwaj.mp4 Gunjan Bhardwaj is the Founder and CEO of the Innoplexus group. He was earlier with the Boston Consulting Group and before that the leader of the global business performance think-tank of Ernst …

How AI and Big Data is transforming the future of healthcare Read More »

aI-blockchain

How AI And Blockchain can revolutionize pharmaceutical trials

It’s widely known by the pharmaceutical community that nearly nine out of ten drug candidates fail to win FDA approval, resulting in enormous drug development expenses every year. Less commonly understood is the underlying cause of these high failure rates, and what the pharmaceutical industry can do to overcome this challenge. Currently, in an effort …

How AI And Blockchain can revolutionize pharmaceutical trials Read More »

STUDY_US-Consumer-Perceptions-of-Pharmaceutical-Companies-01

Our consumer perceptions of Pharma survey: Top ten findings

Download PPT Despite the millions of lives that are saved by pharmaceutical drugs each year, the pharmaceutical industry struggles against an enduring bad reputation. It’s not difficult to find statistics attesting to the frustration that many consumers feel about rising drug prices, corruption, and other real challenges that pharmaceutical companies face. But despite the negative …

Our consumer perceptions of Pharma survey: Top ten findings Read More »